Position in LH
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$24,799,600
-$29,736 QoQ
Shares Held
88,570
-4.8% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#101
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026STIFEL FINANCIAL CORP holds $688,297,489 across 24 Diagnostics & Research names. LH ranks #6 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
633,668 | $317,695,787 | |
| 2 | DHR |
Danaher Corp /De/
|
678,049 | $129,154,772 | |
| 3 | ILMN |
Illumina, Inc.
|
446,598 | $78,525,324 | |
| 4 | DGX |
Quest Diagnostics Inc
|
123,220 | $26,116,476 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
134,890 | $26,063,445 | |
| 6 | LH |
Labcorp Holdings Inc.
This page
|
88,570 | $24,799,600 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
30,389 | $15,997,984 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
26,941 | $14,267,682 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,799,600 | 88,570 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $24,829,336 | 93,060 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $27,158,510 | 108,253 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $33,950,296 | 118,269 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $33,356,092 | 127,066 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $30,214,071 | 129,819 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $139,643,035 | 608,944 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $132,860,423 | 594,507 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $119,296,338 | 586,194 | Shares | Defined | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||